DNTH
Dianthus Therapeutics Inc.
NASDAQ: DNTH · HEALTHCARE · BIOTECHNOLOGY
$87.12
+0.47% today
Updated 2026-05-11
Market cap
$4.76B
P/E ratio
—
P/S ratio
3,564.76x
EPS (TTM)
$-4.23
Dividend yield
—
52W range
$17 – $97
Volume
1.0M
Dianthus Therapeutics Inc. (DNTH) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item |
|---|
| Total assets |
| Cash & equivalents |
| Current assets |
| Total liabilities |
| Current liabilities |
| Long-term debt |
| Shareholder equity |
| Retained earnings |
| Accounts receivable |
| Inventory |
| Goodwill |